Sirius Investors
92.44
0.51%Today
Market Cap
118.44B
Volume
3.56M
52W High
96.25
52W Low
78.97

No historical price data available

No price history data available for the selected time period.

Try selecting a different time range.

Company Overview

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Company Information

CEO
Geoffrey Straub Martha
Sector
Healthcare
Industry
Medical - Devices
Employees
95000

Contact Information

Address
20 On Hatch
Country
IE

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 118.44B market capitalization
  • Trading Volume: 3.56M shares traded today
  • Price Range: 52-week range of $78.97 - $96.25
  • Exchange: Listed on New York Stock Exchange

Financial Metrics

P/E Ratio:25.61
EPS:$3.61
Beta:0.82
Avg Volume:7.83M

Market Analysis for Medtronic plc

Medtronic plc (MDT) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 118.44B, the company represents a significant player in its market. The stock is currently trading at $92.44 with a positivedaily change of 0.51%.

The company's 95000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 25.61, beta of 0.82, and 52-week price range from $78.97 to $96.25when evaluating investment opportunities.

Why Invest in Medtronic plc?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (New York Stock Exchange)
  • • Experienced leadership under Geoffrey Straub Martha
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential